Meet our featured StageBio pathologist, Dr. Shannon Kirejczyk (“Kir-8-sick”), DVM, MPH, PhD, DACVP, Pathologist/Principal Investigator
How long have you worked with StageBio? 1 year.
What are your primary interests within the Pathology space? My focus within StageBio is on the General Toxicology team. I perform preclinical safety assessments and the histopathologic analyses for a variety of investigative type studies. I enjoy the variety of studies I read at StageBio, particularly those involving the immune system. I have a background in ecology and public health, and specialty interests in the pathology of non-traditional animal species such as wildlife and aquatics, and in reproductive and developmental pathology, particularly that of nonhuman primates.
What are your most recent work accomplishments? Since joining StageBio, I have served as the Principal Investigator for numerous general toxicology and investigative type studies to assess the safety and efficacy of test articles. I have also participated in the validation of molecular pathology assays for the Investigative Pathology team. I have ongoing collaborations with academic and government researchers and regularly contribute to peer-reviewed manuscripts. I recently co-authored a chapter entitled Nonhuman Primate Neoplasia, part of a forthcoming pathology textbook “An Atlas of Diagnostic Pathology in Nonhuman Primates” to be published by Springer.
What do you like about the StageBio culture? I love the flexibility of the work, the highly collaborative and supportive culture of StageBio, the diverse expertise of the pathologists and support staff, and the encouragement and training I have received as an early career pathologist in the newly established Mentorship program.
What do you like to do on the weekends? Outside of work, I enjoy spending time outdoors with my husband, our 2.5-year-old son and our two dogs. We love visiting the beach and discovering native wildlife species of the Southeastern U.S.
Thanks, Dr. Kirejczyk, for all you add to the StageBio team! We look forward to seeing all you will continue to accomplish!